Skip to content
Trial Eligibility
Menu

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357

This study is recruiting at 25 US sites in 14 states, according to its ClinicalTrials.gov record last updated .

Summary

This study is open to adults aged 18 years and older with different types of HER2+ cancer that has spread and cannot be removed by surgery. People can take part in this study if their tumours show HER2 aberrations and previous treatment was not successful.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Metastatic Breast Cancer
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Colorectal Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1/2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Boehringer Ingelheim
Last updated on ClinicalTrials.gov
October 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 6

  • The Oncology Institute of Hope and Innovation · Cerritos, CA
  • Ellison Medical Institute · Los Angeles, CA
  • University of California Los Angeles · Los Angeles, CA
  • Valkyrie Clinical Trials · Los Angeles, CA
  • University of California Irvine · Orange, CA
  • Sharp Memorial Hospital · San Diego, CA

Connecticut · 1

  • Yale University School of Medicine · New Haven, CT

Florida · 2

  • Helios CR Inc · Lakeland, FL
  • H. Lee Moffitt Cancer Center and Research Institute · Tampa, FL

Illinois · 1

  • Orchard Healthcare Research Inc.- Skokie · Skokie, IL

Indiana · 1

  • Community Health Network · Indianapolis, IN

Iowa · 1

  • University of Iowa Hospitals and Clinics · Iowa City, IA

Massachusetts · 1

  • Dana-Farber Cancer Institute · Boston, MA

New York · 2

  • Memorial Sloan-Kettering Cancer Center · New York, NY
  • New York Cancer & Blood Specialists · Shirley, NY

Pennsylvania · 1

  • Penn State Milton S. Hershey Medical Center · Hershey, PA

South Dakota · 1

  • Avera Cancer Institute · Sioux Falls, SD

Tennessee · 3

  • Baptist Cancer Center - Memphis · Memphis, TN
  • SCRI Oncology Partners · Nashville, TN
  • Tennessee Oncology, Pllc · Nashville, TN

Texas · 2

  • The Methodist Hospital Research Institute · Houston, TX
  • The University of Texas MD Anderson Cancer Center · Houston, TX

Virginia · 2

  • Inova Schar Cancer Institute · Fairfax, VA
  • Virginia Cancer Specialists, PC · Fairfax, VA

Washington · 1

  • Fred Hutchinson Cancer Research Center · Seattle, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.